Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200215
- Publication type:
- Article
Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 10
Results: 16
1
2
Investigation of quinolone‐tethered aminoguanidine as novel antibacterial agents.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200172
- By:
- Publication type:
- Article
3
Ginkgo biloba in the management of the COVID‐19 severity.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200188
- By:
- Publication type:
- Article
4
Hybrid imidazo[1,2‐a]pyridine analogs as potent ATX inhibitors with concrete in vivo antifibrosis effect.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200171
- By:
- Publication type:
- Article
5
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200170
- By:
- Publication type:
- Article
6
Editorial Board: Arch Pharm (10/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202270022
- Publication type:
- Article
7
Cover Picture: Arch Pharm (10/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202270021
- Publication type:
- Article
8
Synthesis of new N‐(3‐oxo‐1‐thia‐4‐azaspiro[4.5]decan‐4‐yl)pyridine‐3‐carboxamide derivatives and evaluation of their anti‐influenza virus and antitubercular activities.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200224
- By:
- Publication type:
- Article
9
Design, synthesis, and in silico studies of tetrahydropyrimidine analogs as urease enzyme inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200158
- By:
- Publication type:
- Article
10
Discovery of novel α‐carboline derivatives as glycogen synthase kinase‐3β inhibitors for the treatment of Alzheimer's disease.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200156
- By:
- Publication type:
- Article
11
Design, synthesis, biological evaluation, and in silico studies of 2‐aminobenzothiazole derivatives as potent PI3Kα inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200146
- By:
- Publication type:
- Article
12
Pyrazolopyrimidines as attractive pharmacophores in efficient drug design: A recent update.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200154
- Publication type:
- Article
13
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluation.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200133
- By:
- Publication type:
- Article
14
Synthesis and antitumor activity of novel hybrid compounds between 1,4‐benzodioxane and imidazolium salts.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200109
- By:
- Publication type:
- Article
15
Synthesis and biological evaluation of sulfonamide‐based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200070
- By:
- Publication type:
- Article
16
Insights into modulating the monastrol scaffold: Development of new pyrimidinones as Eg5 inhibitors with anticancer activity.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 10, p. 1, doi. 10.1002/ardp.202200029
- By:
- Publication type:
- Article